埃万特的产品不为以下目的或用途而设计，也不会宣传或预期用于以下目的或用途：(a) 被美国食品药品监督管理局（FDA）或国际标准化组织（ISO）归类为“植入”类器械的医疗器械；或美国药典（USP）或ISO标准定义的“永久”使用器械；或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械；或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。

埃万特的产品不为以下目的或用途而设计，也不会宣传或预期用于以下目的或用途：(a) 被美国食品药品监督管理局（FDA）或国际标准化组织（ISO）归类为“植入”类器械的医疗器械；或美国药典（USP）或ISO标准定义的“永久”使用器械；或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械；或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。

Francisco Nakasato, Bairro São Roque das Chaves 1700 Itupeva SP 13295-000 Brazil Avient Belgium SA Design and manufacture of color and additive concentrates, thermoplastic resins and specialty compounds Rue Melville Wilson 2, B-5330 Assesse, Belgium Magna Colours Limited The design, manufacture and distribution of specialty colouration products and chemical auxiliaries for us in the textile, dying, printing and finishing industries.

Le informazioni personali sono tutte quelle informazioni che possono essere usate per identificare qualcuno, come: • numeri di identificazione rilasciati dal governo, come numeri di previdenza sociale • informazioni sulle retribuzioni • anamnesi medica • documenti sulle performance • indirizzi e numeri di telefono personali Uso di internet e delle e-mail Avient offre ai nostri dipendenti l’accesso a diverse forme di strumenti elettronici per uso aziendale. Corruzione e mazzette In nessuna circostanza è accettabile offrire, dare, accettare o richiedere forme di tangenti, mazzette o incentivi. Non devono offrire, dare, accettare o richiedere forme di tangenti o mazzette, né adottare condotte illecite o immorali.

a) 米国食品医薬品局（FDA）または国際標準化機構（ISO）により「インプラント」機器として分類される医療機器、または米国薬局方（USP）または ISO 規格で定義される「パーマネント」 機器、または (b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または (c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。

Avient can provide its NDA form upon request

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.